1
Total investments
0
Early stage
1
Mid stage
0
Late stage
4y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Nov 2022
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date.
Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
Experience · 3 entries
All (3)
Investments (1)
2022
Angel Investor
Nov 2022
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date.
Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
2019
Advisor, Growth & Marketing
Aug 2019
CapitalG is Alphabets independent growth fund. We invest capital to help remarkable entrepreneurs and leading transformational companies accelerate the growth of their businesses.
2015
Senior Manager, Strategy and M&A
Sep 2015
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Tevas Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/